Clinical reference Biomarker Directory
Back to directory

Chemokine interferon inducible protein 10

Emerging

CXCL10, alongside CXCL9, supports HLH/MAS diagnosis as part of the interferon-gamma-driven inflammatory marker panel.

Also known as CXCL10 IP-10 interferon gamma-induced protein 10
In plain language

CXCL10 is released when interferon-gamma signaling is very active, which happens in a dangerous immune overactivation condition called HLH. It's tested alongside several related markers to help confirm this diagnosis in critically ill patients.

Biomarker & context

CXCL10 (IP-10) is an interferon-gamma-induced chemokine that recruits activated T-cells to sites of inflammation, with particular relevance to hyperinflammatory syndromes.

What it indicates

Alongside CXCL9 (discussed separately in this set), CXCL10 is part of the interferon-gamma-driven inflammatory cascade increasingly used to support diagnosis and severity assessment of hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS).

Diagnosis & clinical testing

Measured via serum immunoassay, typically as part of a broader cytokine panel alongside ferritin, soluble CD25, IL-18, and CXCL9 when HLH/MAS is suspected in a critically ill patient.

Guiding treatment

Elevated CXCL10, especially alongside the other interferon-driven markers in this panel, supports more confident HLH/MAS diagnosis and can help guide the decision to escalate to HLH-directed immunosuppressive therapy.

Clinical significance

Part of an actively evolving, more sophisticated cytokine panel approach to diagnosing hyperinflammatory syndromes.

References
  1. General hematology/immunology reference literature on interferon-gamma-induced chemokines (CXCL9, CXCL10) in HLH/MAS diagnosis.